Accenture Up; Synopsys Jumps 9% — Moderna Plummets After Citi Calls Sell


Accenture beats revenue and bookings estimates; Synopsys raises long-term targets; Citi downgrades Moderna after 600% rally, calling valuation unjustifiable.

Editorial companion

What stands out

Bloomberg hosts flagged three different investor stories in one market snapshot: Accenture beat revenue and new bookings estimates and announced cloud deals, Synopsys pushed stronger long-term targets that sent the stock up, and Citi told clients to sell Moderna after a 600 percent rally, calling the valuation unjustifiable. The Citi call is the sharpest soundbite, it frames Moderna’s recent jump as a valuation event rather than fresh evidence of durable commercial traction. The juxtaposition of corporate beats and an analyst-driven downgrade makes the clip a neat study in how news, guidance and one analyst note can move prices on the same day.